Journal
CELL PROLIFERATION
Volume 51, Issue 5, Pages -Publisher
WILEY
DOI: 10.1111/cpr.12465
Keywords
cancer; chemotherapy; diagnosis; dysregulation; miR-149; prognosis
Categories
Funding
- National Natural Science Foundation of China [81772996, 81472266]
- Excellent Youth Foundation of Jiangsu Province, China [BK20140032]
Ask authors/readers for more resources
MicroRNAs are small non-coding RNAs that play critical roles in the regulatory mechanisms involving cell differentiation, proliferation, apoptosis and tumorigenesis. Recent research efforts have been conducted to apply these discoveries into clinical functions, including the early diagnosis and therapeutic outcome of patients with cancer. Previous studies have shown that microRNA-149 (miR-149) is dysregulated in various human cancers and exerts its effects on tumorigenesis and tumour progression. In this review, we summarized the potential roles of miR-149 dysregulation and its target genes during tumorigenesis and clinical treatment of human cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available